Abstract: The present invention relates to a hyaluronic acid-based hydrogel which is a hyaluronic acid-peptide crosslinked body crosslinked using a peptide crosslinking agent. More specifically, the present invention relates to a hyaluronic acid-based hydrogel and a method for producing same, wherein a crosslinked body having novel physical properties is obtained using a relatively small amount of a crosslinking agent that forms peptide bonds, unlike conventional crosslinking agents, and the hyaluronic acid-based hydrogel has the advantages of: being safe and having few side effects; the physical properties of a filler being adjustable according to the amount of peptide crosslinking; and having a high elasticity ratio.
Type:
Grant
Filed:
March 16, 2021
Date of Patent:
May 19, 2026
Assignee:
CHAMEDITECH CO., LTD.
Inventors:
Kyeong-Yong Park, Jun-Goo Kang, Seoung Jin Lee, Sok Jin Kim
Abstract: The present invention relates to a novel organic compound, a near-infrared fluorescent constant medium containing the same, and a method for nano-granulating the constant medium.
Type:
Grant
Filed:
January 11, 2016
Date of Patent:
December 3, 2019
Assignees:
COLLEGE OF MEDICINE POCHON CHA UNIV. INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHAMEDITECH CO., LTD.
Inventors:
Tae Jong Yoon, Kwang Hoe Chung, Jeongbeob Seo, Sin Wook Kang, Kwang Hyuong Lee, Yong Su Kwon, Hye Sun Jeon, Chae Woon Lee, Jin Sung Kim